Duke-NUS-led research reveals an intranasal vaccine candidate that offers superior, long-lasting COVID-19 immunity, potentially minimizing booster requirements. Novel findings from a preclinical head-to-head comparison show…

Duke-NUS-led research reveals an intranasal vaccine candidate that offers superior, long-lasting COVID-19 immunity, potentially minimizing booster requirements. Novel findings from a preclinical head-to-head comparison show…
xAI owned by American tech billionaire Elon Musk, is set to release its latest chatbot, …